Myriad Genetic Laboratories, the Utah-based company that owns the patents on the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2, has struck a deal with the US National Institutes ...

The FDA made a point to note that there are more than 1,000 cancer-related mutations in BRCA genes, and just about 2 percent of Ashkenazi Jewish women carry the three mutations in the test. They are ...

With women being diagnosed with cancer at younger ages, doctors are working to avoid that diagnosis altogether. Genetic testing can help spot an issue early on. Underwater Volcano Off Coast of ...

University of Massachusetts Amherst cancer researchers hope to change that by developing a new, noninvasive test that uses women's breast milk to detect breast cancer in its earliest stages. New ...

Gabriel N. Mannis, M.D., and colleagues with the University of California, San Francisco, surveyed 1,077 women after BRCA testing to identify the prevalence and post-test predictors of risk ...

My cousin's positive test for the BRCA1 gene mutation, specifically the 187 delAG mutation, facilitated my own BRCA testing, ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

During the first year of the NHS Jewish BRCA Testing Programme some 25,000 free saliva test kits have been requested and delivered. Around 11,000 tests have now been processed, with 235 people (2. ...

During the first year of the NHS Jewish BRCA Testing Programme, around 25,000 free saliva test kits have been requested and delivered. Some 11,000 individuals have undergone testing, and of those ...